Moreover, both ILC1s and ILC3s possess the ability to directly eliminate tumor cells by expressing TRAIL, thereby imbuing these cells with the potential of anti-tumor effector cells (94) (Figure 1). The gene discussed is TNFSF10; the disease is neoplasm.